https://adisinsight.springer.com/trials/700392006?error=cookies_not_supported&code=761c6518-3e5c-491a-81eb-ddf067877283
Phase1b/2 Trial Of AZA + APG1252 In Patients With High-Risk AML - AdisInsight
This is a phase Ib/II study that aims to investigate the safety, tolerability and explore the efficacy of BCL- XL inhibition in participants with high-risk AML.